• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Childhood pneumonia can be treated at home, say scientists

Snowy Owl

Retired in 2010, In Memoriam
Childhood pneumonia can be treated at home, say scientists


Thu Jan 3, 2008 9:12pm EST

<script language="javascript"> var storyKeywords = "US PNEUMONIA CHILDREN"; var RTR_ArticleTitle = "Childhood pneumonia can be treated at home, say scientists"; var RTR_ArticleBlurb = "By Will Dunham WASHINGTON (Reuters) - Treating severe pneumonia in children at home with oral antibiotics works just as well as treating them with intravenous drugs at a hospital as advised by the World Health Organization, scientists said on..."; </script> <script language="javascript">addImpression("460314_Article Tools");</script> <script type="text/javascript"> var showComments = false; /** START SITELIFE INTEGRATION **/ var uniqueArtKey = "USN029027120080104"; var articleUrl = document.location.href.split("?")[0]; var tempTitle = unescape("Childhood+pneumonia+can+be+treated+at+home%2C+say+scientists"); tempTitle = replaceString("+", " ", tempTitle); var articleTitle = tempTitle; var articleSection = "Main_US"; var articleCategories = document.location.href.split("article/")[1].split("/")[0]; var slArtPage = new SLSectionPage(); slArtPage.varName = "slArtPage"; slArtPage.base.varName = "slArtPage"; function singlePageView() { document.location.href = ReplaceQueryStringParam(document.location.href, "sp", "true"); } function replaceString(oldS, newS, fullS) { // Replaces oldS with newS in the string fullS for (var i = 0; i < fullS.length; i++) { if (fullS.substring(i, i + oldS.length) == oldS) { fullS = fullS.substring(0, i) + newS + fullS.substring(i + oldS.length, fullS.length); } } return fullS; } </script> <input name="CurrentSize" id="CurrentSize" type="hidden"> <script language="javascript" src="http://www.reuters.com/resources/js/shareStub.js"></script><script language="javascript" src="http://www.reuters.com/resources/js/shareFunctions.js"></script> Email | Print | Share
| Reprints | Single Page | <script type="text/javascript">slArtPage.addRecommendWidget(uniqueArtKey);</script>Recommend (-)
[-] Text [+]

<script language="javascript"> var intSlideshowPosition = 0; var arrArticleImageIds = new Array(); var arrArticleImages = new Array(); var intSlideshowTracking = false; arrArticleImageIds.push(2658212); var re = /\\/gi; var strippedPhotoHTML = '
forum
'; arrArticleImages.push(strippedPhotoHTML.replace(re, "")); function loadInlineImage(intIndex) { document.getElementById("articlePhoto").innerHTML = '' + arrArticleImages[intIndex] + ''; document.getElementById("slideshowStatus").innerHTML = (intIndex + 1) + " of " + arrArticleImageIds.length; if (intSlideshowTracking == true) { dcsMultiTrack('DCSext.VirtualEvent', '1', 'DCSext.rChannel','Inline Slideshow','WT.cg_n','Inline Slideshow - Photo','WT.cg_s','','DCSext.DartZone','','DCSext.ContentType','Pictures'); } } function launchArticleSlideshow() { commonPopup('/news/pictures/articleslideshow?articleId=USN029027120080104&channelName=topNews#a='+(intSlideshowPosition+1)+'',920,585,3,'reutersSlideshow'); } function drawControls() { if (arrArticleImageIds.length > 1) { document.write(''); document.write('
btn_inlineslide_prev.gif
'); document.write('
btn_inlineslide_next.gif
'); document.write('1 of ' + (arrArticleImageIds.length) + ''); document.write('Full Size
'); document.getElementById("articlePhoto").className = "articlePhoto"; } else { document.write(''); document.write('1 of 1'); document.write('Full Size
'); document.getElementById("articlePhoto").className = "articlePhoto"; } } function nextSlide() { if (intSlideshowPosition < arrArticleImageIds.length - 1) { intSlideshowPosition++; } else { intSlideshowPosition = 0; } intSlideshowTracking = true; loadInlineImage(intSlideshowPosition); } function prevSlide() { if (intSlideshowPosition > 0) { intSlideshowPosition--; } else { intSlideshowPosition = arrArticleImageIds.length - 1; } intSlideshowTracking = true; loadInlineImage(intSlideshowPosition); } function buttonMenu() { return false; } function buttonPush(e) { if (!e) var e = window.event; if (e.button != 2) { document.getElementById(this.id).style.cssText = "margin: 2px 0px 0px 2px;"; } } function buttonRelease(e) { if (!e) var e = window.event; if (e.button != 2) { document.getElementById(this.id).style.cssText = "margin: 1px;"; } } function initSlideshow() { if (arrArticleImageIds.length > 1) { document.getElementById("slideshowL").onclick = prevSlide; document.getElementById("slideshowR").onclick= nextSlide; document.getElementById("slideshowL").oncontextmenu = buttonMenu; document.getElementById("slideshowR").oncontextmenu= buttonMenu; document.getElementById("slideshowL").onmousedown = buttonPush; document.getElementById("slideshowR").onmousedown = buttonPush; document.getElementById("slideshowL").onmouseup = buttonRelease; document.getElementById("slideshowR").onmouseup = buttonRelease; } } </script> <table style="float: left;" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td class="articlePhoto" id="articlePhoto" align="center" valign="middle"> </td></tr></tbody></table> <script language="javascript"> drawControls(); </script>1 of 1Full Size
<script language="javascript">addImpression("460325_Related Video");</script> <script language="javascript">addImpression("460326_Related News");</script>
powered by
iconSphere.gif
Sphere


<script> var adsrc = 'reuters.com.dart/news/top/article;' + (typeof(seg)=='undefined'?'':seg) + 'type=featured_broker;sz=170x40;articleID=USN029027120080104;ord=' + (typeof(tmstmp)!='undefined'?tmstmp:12345) + '?'; </script>







<!-- END:: Broker Center Advert Module -->
By Will Dunham
WASHINGTON (Reuters) - Treating severe pneumonia in children at home with oral antibiotics works just as well as treating them with intravenous drugs at a hospital as advised by the World Health Organization, scientists said on Thursday.
Pneumonia is one of the world's leading child killers, particularly in South Asia and sub-Saharan Africa.
The researchers said their findings in this study of 2,037 children ages 3 to 5 in Pakistan should prompt the U.N. health agency to change its recommendations on treating severe childhood pneumonia.
The WHO advises that children with severe pneumonia be referred to a hospital and treated with intravenous antibiotics. But many sick children in developing nations are unable to reach a hospital for such treatment, the researchers said. And oral treatment at home is much cheaper, they added.
About 2 million of the 10 million deaths annually in children under age 5 worldwide are caused by pneumonia -- an inflammation of the lungs caused by an infection.
"It exceeds malaria, it certainly exceeds HIV and it exceeds diarrheal diseases, too," Dr. Donald Thea of the Boston University School of Public Health, one of the researchers, said in a telephone interview.
The study involved children with severe pneumonia who arrived at hospitals in seven locations in Pakistan. About half were sent home to take an oral antibiotic, amoxicillin, in syrup form. The others were treated intravenously in the hospital with an equivalent antibiotic, ampicillin.
STUDY: HOME TREATMENT SAFE, EFFECTIVE
The treatment at home was just as safe and effective as the hospital treatment, the study found. Of the five children who died within 14 days of entering the study, one was treated at home, with the other four among the hospitalized.
WHO guidelines call for children with pneumonia that is not severe to be treated at home with oral antibiotics, but hospitalization and intravenous antibiotics for severe cases.
The researchers said the WHO guidelines can be ineffective in practice because many children with severe pneumonia in developing countries who are referred to hospitals for treatment never reach them because they have no means of transportation or are too far away.
The researchers envision medicine distribution to children with pneumonia by health-care workers in local communities.
Treatment with oral antibiotics also avoids the possibility of infection that can occur with administering intravenous drugs due to factors like unsterile needles, they added.
"Safe community-based treatment alternatives will substantially increase the number of children who can receive effective care" and save lives and money, the researchers wrote in the Lancet medical journal.
In an commentary accompanying the study, Dr. Shams El Arifeen of the International Centre for Diarrhoeal Disease Research in Bangladesh and Dr. Abdullah Baqui of Johns Hopkins University in Baltimore called the study "a milestone."
The findings should change the management of severe pneumonia in children in developing countries, they added, writing: "The potential impact here is enormous, particularly for the many children with severe pneumonia who are referred to hospitals but never reach them."
Thea said the findings and other data will be presented to the WHO next month, with the hope of getting new treatment recommendations in about nine months to a year.


(Editing by Stacey Joyce)



© Reuters 2008 All rights reserve

http://www.reuters.com/article/topNews/idUSN029027120080104?feedType=RSS&feedName=topNews&sp=true
 
Severe pneumonia in children treatable at home-WHO

Severe pneumonia in children treatable at home-WHO

Severe pneumonia in children treatable at home-WHO

Thu Jan 3, 2008 7:01pm EST
By Laura MacInnis

GENEVA, Jan 4 (Reuters) - Treating children stricken with severe pneumonia at home, instead of sending them to hospital, could save scores of lives in poor nations, the World Health Organisation (WHO) said on Friday.

Citing a Boston University School of Public Health study it helped support, the WHO said that antibiotic pills given at home were as effective as injectible antibiotics against pneumonia, the largest killer of children under five years old.

Every minute, four children die from the lung inflammation, which can range in seriousness from mild to life-threatening. Pneumonia acquired in hospital can be particularly virulent.

Most developed-world cases of pneumonia develop from a viral infection, but in developing nations, where children are most affected, about 60 percent of cases are caused by bacteria that can be treated with antibiotics.

Under current WHO guidelines, children with mild pneumonia are given oral antibiotics and more severe cases are referred to hospitals for treatment with antibiotics by injection.

But in poor countries, families often cannot easily access hospitals, and many children die before they reach hospital or are too sick to be treated once they arrive.

"In addition, children with severe pneumonia are vulnerable to infections as a result of weak immunity and could be at increased risk in crowded hospital wards," according to the United Nations health agency.

It said it would revise its guidance this year in light of the research involving 2,037 children in Pakistan, which showed a treatment failure rate of 7.5 percent among children given drugs at home, compared to 8.6 percent among those in hospital.

Some children with very severe pneumonia will still require injectible antibiotics in hospital, the study found.

"The potential impact of these results is enormous," said Shamim Qazi, a medical officer with the WHO's department of child and adolescent health and development, who co-authored the study appearing in the Lancet medical journal.

"Being able to treat children with severe pneumonia safely and effectively in their own homes would be of huge benefit to both families and health systems, by reducing the need for admission to hospital," Qazi said.

A WHO spokeswoman said the oral antibiotic typically used to fight pneumonia is amoxicillin, a penicillin-based formulation also used for ear, bladder and other infections. Amoxicillin is produced by pharmaceutical companies including GlaxoSmithKline (GSK.L: Quote, Profile, Research) and is also available as a generic medicine.

http://www.reuters.com/article/latestCrisis/idUSL0363306
 
Re: Childhood pneumonia can be treated at home, say scientists

Managing severe pneumonia in children in developing countries

Despite advances in our understanding of the epidemiology and<sup> </sup>distribution of deaths from pneumonia,<sup>1</sup> more than 150 million<sup> </sup>cases of pneumonia still occur annually, with almost 2.4 million<sup> </sup>deaths worldwide. Pneumonia is perhaps the most frequent cause<sup> </sup>of death in children under 5, including during the newborn period.<sup>2</sup><sup> </sup>Deaths from pneumonia in children have increased in the wake<sup> </sup>of the HIV epidemic in Africa. Most deaths occur early in the<sup> </sup>course of illness. Because severe pneumonia is usually related<sup> </sup>to bacterial infection, treatment has largely focused on various<sup> </sup>antibiotic strategies.

<sup> </sup>
In the accompanying randomised controlled trial, Asghar and<sup> </sup>colleagues compare the effectiveness of injectable ampicillin<sup> </sup>plus gentamicin or chloramphenicol in children aged 2-59 months<sup> </sup>with severe pneumonia (defined by World Health Organization<sup> </sup>criteria).<sup>3</sup> The trial took place in inpatient wards in tertiary<sup> </sup>care hospitals in Bangladesh, Ecuador, India, Mexico, Pakistan,<sup> </sup>Yemen, and Zambia. Significantly more children failed treatment<sup> </sup>with chloramphenicol <nobr>. . .</nobr> [Full text of this article]

Zulfiqar A Bhutta, Husein Lalji Dewraj professor and chairman

<sup>1</sup> Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan
zulfiqar.bhutta@aku.edu



http://www.bmj.com/cgi/content/extract/336/7635/57
 
Back
Top